Manipal Health Enterprises shares debuted at an 11% premium over the IPO price, beating grey market expectations. Brokerages remain constructive on the hospital chain’s long-term prospects, though some caution that valuations are rich. Here’s what experts recommend for allotted investors and those considering fresh entry.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.